Patient-derived xenograft models may become an indispensable tool in precision oncology

Patient-derived xenograft models may become an indispensable tool in precision oncology

Cancer remains one of the most pressing global health challenges, with millions of new diagnoses each year. While precision medicine and targeted therapies have transformed treatment strategies, many patients still face drug resistance and disease recurrence.

Revolutionizing Cancer Research: The Emergence of Patient-Derived Xenograft

Cancer remains a formidable adversary in global health, affecting millions annually and presenting persistent challenges to effective treatment. Despite significant advances through precision medicine and targeted therapies that have reshaped oncology, the issues of drug resistance and disease recurrence continue to plague many patients. A seminal review recently published in Genes & Diseases sheds light on the revolutionary potential of patient…

ANGLE’s Parsortix system used in new cancer biology research - Pharmafile

ANGLE has announced three new peer-reviewed publications demonstrating the use of its Parsortix circulating tumour cell (CTC) harvesting system in studies exploring cancer biology and therapeutic targets. The research, led by academic groups in Germany, Ireland and the US, supports the system’s growing role in advancing oncology R&D. In one study, published in Journal of […] The post ANGLE’s Parsortix system used in new cancer biology research a…